Lantern Pharma Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Lantern Pharma Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2019 to 2023.
  • Lantern Pharma Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $54.7K.
  • Lantern Pharma Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$500K, a 77.1% increase from 2022.
  • Lantern Pharma Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$2.18M, a 103% decline from 2021.
  • Lantern Pharma Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $63.4M, a 168% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$500K +$1.68M +77.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-18
2022 -$2.18M -$65.6M -103% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-18
2021 $63.4M +$39.8M +168% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-20
2020 $23.7M +$20.7M +710% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 $2.92M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.